首页> 中文期刊> 《中国药物与临床》 >骨孤立性浆细胞瘤10例临床病理分析

骨孤立性浆细胞瘤10例临床病理分析

         

摘要

Objective To explore the diagnosis and treatment of solitary plasmacytoma of bone (SPB) and to summarize its clinicopathological features. Methods The clinical data of 10 SPB patients were retrospectively ana-lyzed. The clinical features, diagnostic criteria, treatment and prognosis were summarized. Results All the 10 pa-tients were confirmed by pathology as SPB and fulfilled the diagnostic criteria. The average age of onset was 54 years. Seven patients received radiotherapy after operation. The follow-up ranged from 5 to 120 months. The median follow-up time was 37.5 months. One patient had local recurrence, and another progressed into multiple myeloma (MM). Two patients died of infection. The 5-year survival rate was 70%. Conclusion SPB is more likely to occur in middle-aged and elderly patients. As a rare low-grade malignant tumor, SPB is confirmed mainly by pathology and usually presents with a favorable prognosis. Some patients may progress into MM. Radiotherapy at a proper dose combined with surgery may be the optimal choice of treatment.%目的 探讨骨孤立性浆细胞瘤(SPB)的诊断和治疗,总结其临床病理特点.方法 回顾性分析10例SPB患者的临床资料,并对其临床特点、诊断标准、治疗和预后进行总结.结果 10例患者均经病理证实为SPB并符合其诊断标准,中位发病年龄54岁,7例患者术后接受放疗.随访5~120个月,中位随访时间为37.5个月,其中1例局部复发,1例进展为多发性骨髓瘤(MM),2例患者感染死亡,5年生存率为70%.结论 SPB好发于中老年,是少见的低度恶性肿瘤,主要依靠病理确诊,预后较好,部分可转化为MM.适当剂量的放疗结合手术可能是其治疗的最佳手段.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号